4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-23-057725
Chief Executive Officer sold 19,050 shares at an average $2.29 ($43,684)
- Chief Executive Officer acquired 70,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Walker Marlan D · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-05 | Exercise or conversion : show line 1 in the form | +70,000 | 81,615 | D | ||
| 2023-12-06 | Sale : show line 2 in the form | −14,500 | $2.31 | $33,496 | 67,115 | D |
| 2023-12-07 | Sale : show line 3 in the form | −4,550 | $2.24 | $10,187 | 62,565 | D |
| Open-market sales · 19,050 sh · avg $2.29 · $43,684 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-05 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −70,000 | 0 | D |
Loading xslF345X05/doc4.xml…